OrthoPediatrics Corp.
NASDAQ:KIDSMedical - Devices
+$0.19 today
- Market cap
- $826.40M
- Beta
- 1.01
- P/E (TTM)
- -11.0
- EPS (TTM)
- -$1.68
Volume 0.16M
Average 0.16M
KIDS Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
OrthoPediatrics Corp.NASDAQ: KIDS
Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026
Depreciation & amortization grows in line with its trailing trend
Q1 FY2026 depreciation & amortization of $5.72M rose 13.3% year over year, behind the +14.1% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 2.1% from the prior quarter. Over 3 fiscal years it compounded at +17.3% a year.
Context
- Depreciation & amortization amounted to 8.9% of revenue in FY2025, down 0.4 pp from a year earlier.
- Depreciation & amortization increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +13.3% toward the trailing-twelve-month pace of +14.1%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the cash flow
- Latest · FY2025
- 21.12M USD
- Year-over-year change
- +10.7%
- 4-year CAGR
- +18.6%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 21.12M | +10.7% |
| FY2024 | 2024-12-31 | 19.08M | +9.7% |
| FY2023 | 2023-12-31 | 17.39M | +32.7% |
| FY2022 | 2022-12-31 | 13.1M | +22.6% |
| FY2021 | 2021-12-31 | 10.68M | — |
Depreciation & Amortization vs competitors
How KIDS compares with its peers on the latest reported figures
- KIDS's LTM Mar 2026 depreciation & amortization of $21.79M is the 2nd largest of the 8 companies compared; the peer median is $9.02M.
- Its year-over-year change of +14.1% is the 2nd highest of 8, against a peer median of -6.6%.
- Depreciation & amortization amounts to 9.0% of revenue for KIDS, versus a peer median of 3.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $46.35M | -6.6% | -5.3% | 8.0% | |
| LTM Mar 2026 | $21.79M | +14.1% | +17.3% | 9.0% | |
| LTM Mar 2026 | $10.99M | -30.6% | -51.5% | 12.7% | |
| LTM Mar 2026 | $9.61M | +52.7% | +24.8% | 3.2% | |
| LTM Mar 2026 | $9.02M | +0.5% | +70.1% | 4.4% | |
| LTM Mar 2026 | $3.32M | +1.4% | -6.7% | 2.6% | |
| LTM Mar 2026 | $3.25M | -50.6% | +16.3% | 0.6% | |
CBLLCeriBell, Inc. | LTM Mar 2026 | $640K | -47.5% | — | 0.7% |
| Peer median (excluding KIDS) | $9.02M | -6.6% | +5.5% | 3.2% | |
Competitors are the stored peer set for KIDS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (16.26M) | 1.26M | (20.97M) | (37.82M) | (39.65M) |
| Depreciation & Amortization | 10.68M | 13.1M | 17.39M | 19.08M | 21.12M |
| Deferred Income Tax | (1.13M) | (5.03M) | (1.16M) | (4.74M) | (153K) |
| Stock-Based Compensation | 5.84M | 6.68M | 10.53M | 13.55M | 17.78M |
| Change in Working Capital | (12.55M) | (17.76M) | (32.2M) | (22.94M) | (10.79M) |
| Accounts Receivables | (466K) | (3.98M) | (9.72M) | (4.75M) | (9.37M) |
| Inventory | (5.05M) | (16.94M) | (26.28M) | (13.2M) | (8.47M) |
| Accounts Payables | (567K) | (209K) | 1.49M | (4.28M) | 8.17M |
| Other Working Capital | (6.47M) | 3.37M | 2.32M | (709K) | (1.12M) |
| Other Non-Cash Items | 354K | (20.01M) | (623K) | 5.82M | 6.85M |
| Operating Cash Flow | (13.06M) | (21.77M) | (27.05M) | (27.05M) | (4.85M) |
| Capital Expenditures | (16.01M) | (10.03M) | (18.98M) | (14.26M) | (11.11M) |
| Acquisitions (Net) | 0 | (40.09M) | (3.64M) | (20.23M) | (15.5M) |
| Purchases of Investments | 0 | (110.12M) | (48.6M) | (25.65M) | (17.02M) |
| Sales of Investments | 9.25M | 46.87M | 112.9M | 49.86M | 0 |
| Other Investing Activities | (650K) | 0 | (2.11M) | (2.88M) | 0 |
| Investing Cash Flow | (7.41M) | (113.37M) | 41.68M | (13.16M) | (43.63M) |
| Debt Repayment | (131K) | (137K) | 9.28M | 56.54M | 23.98M |
| Common Stock Issued | 137K | 139.28M | 21K | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | (3.17M) | (2M) | (3.41M) | 0 |
| Financing Cash Flow | 6K | 135.97M | 7.3M | 53.14M | 23.98M |
| Effect of Forex Changes | (658K) | 619K | 633K | (175K) | 348K |
| Net Change in Cash | (21.13M) | 1.46M | 22.57M | 12.75M | (24.16M) |
| Free Cash Flow | (29.07M) | (31.8M) | (46.03M) | (41.31M) | (15.96M) |
OrthoPediatrics Corp.
NASDAQ:KIDS
Intrinsic Alpha fair value
Locked
Current Price
$31.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.